Beta Bionics Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the second quarter 2026, Beta Bionics Inc 's inventory turnover ratio sequentially decreased to 2.23 in the second quarter 2026, otherwise the ratio remained above the average, as BBNX's markets remain strong.Beta Bionics Inc 's average inventory processing period in the Jun 30 2026 quarter, has increased to 164 days, from 162 days, in the Mar 31 2026 quarter.

Within Healthcare sector 176 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1183 in the first quarter 2026, to 1453.

BBNX Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Beta Bionics Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

BBNX Inventory Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Inventory Growth	38.07 %	50.84 %	63.08 %	1536.39 %	-
Y / Y Cost of Sales Growth	31.11 %	37.5 %	59.98 %	54.02 %	43.64 %
Inventory Turnover Ratio (TTM)	2.23	2.26	2.34	2.32	2.9
BBNX's Total Ranking	# 1453	# 1183	# 872	# 223	# 0
Average inventory processing period	163	161	156	157	126
Seq. Inventory Growth	0.8 %	9.23 %	6.62 %	17.61 %	10.13 %
Seq. Cost of Sales Growth	19.19 %	-21.43 %	16.67 %	20 %	25 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 74
Healthcare Sector	# 177
Overall Market	# 1453

Inventory Turnover Ratio Statistics
High	Average	Low
2.34	2.16	1.8
(Dec 31 2025)		(Sep 30 2025)

BBNX Company Profile >> Back to BBNX Efficiency Comparisons >> Compare BBNX Inventory Turnover Ratio to its Competitors

Financial Statements
Beta Bionics Inc 's Inventories	$ 24 Millions	Visit BBNX's Balance sheet
Beta Bionics Inc 's Cost of Revenues TTM	$ 50 Millions	Visit BBNX's Income Statement
What are BBNX's Sales?		Visit BBNX's Sales by Segment

Other Inventory Turnover Ratios
Beta Bionics Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
BBNX's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for BBNX's Competitors
Inventory Turnover Ratio for BBNX's Suppliers
Inventory Turnover Ratio for BBNX's Customers

You may also want to know
BBNX's Sales Growth Rates	BBNX's Pe Price to earnings ratio	BBNX's Receivables Turnover Ratio	BBNX's Stock Quote
BBNX's Net Income Growth Rates	BBNX's Ps Price to Sales ratio	BBNX's Sales per Employee	BBNX's Asset Turnover Ratio
BBNX's Net Margin	BBNX's Pb Price to Book ratio	BBNX's Financial Strength Ratios	BBNX's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Jun 30 2026	Inventories at quarter ending Jun 30 2026
Sharps Technology Inc	5.68	$ 2.869 Millions	$ 1 Millions
Opko Health Inc	5.42	$ 348.206 Millions	$ 64 Millions
Charles River Laboratories International inc	5.39	$ 1,761.363 Millions	$ 327 Millions
Harrow Inc	4.93	$ 73.636 Millions	$ 15 Millions
West Pharmaceutical Services Inc	4.72	$ 2,103.100 Millions	$ 445 Millions
Henry Schein Inc	4.68	$ 9,342.000 Millions	$ 1,997 Millions
Guardant Health Inc	4.53	$ 413.947 Millions	$ 91 Millions
Idexx Laboratories Inc	4.44	$ 1,714.440 Millions	$ 386 Millions
Scilex Holding Company	4.08	$ 14.867 Millions	$ 4 Millions
Medinotec Inc	4.08	$ 4.736 Millions	$ 1 Millions
3m Company	4.07	$ 15,258.000 Millions	$ 3,754 Millions
Electromed Inc	4.02	$ 14.133 Millions	$ 4 Millions
Novocure Limited	4.02	$ 166.921 Millions	$ 41 Millions
Elite Pharmaceuticals Inc	3.95	$ 78.824 Millions	$ 20 Millions
Lftd Partners Inc	3.89	$ 29.233 Millions	$ 8 Millions
Pmgc Holdings Inc	3.87	$ 1.364 Millions	$ 0 Millions
Intelligent Bio Solutions Inc	3.80	$ 2.165 Millions	$ 1 Millions
Iridex Corp	3.80	$ 32.517 Millions	$ 9 Millions
Teva Pharmaceutical Industries Limited	3.66	$ 8,232.000 Millions	$ 2,250 Millions
Beyond Air Inc	3.51	$ 6.447 Millions	$ 2 Millions
Nexgel Inc	3.49	$ 7.577 Millions	$ 2 Millions
Lifeward ltd	3.47	$ 13.976 Millions	$ 4 Millions
Bellevue Life Sciences Acquisition Corp	3.38	$ 1.215 Millions	$ 0 Millions
10x Genomics Inc	3.29	$ 184.539 Millions	$ 56 Millions
Maravai Lifesciences Holdings Inc	3.22	$ 135.038 Millions	$ 42 Millions
Mettler toledo International Inc	3.18	$ 1,277.460 Millions	$ 401 Millions
Bionexus Gene Lab Corp	3.15	$ 2.362 Millions	$ 1 Millions
Mimedx Group Inc	3.07	$ 75.981 Millions	$ 25 Millions
Msa Safety Inc	2.92	$ 1,021.036 Millions	$ 350 Millions
Ligand Pharmaceuticals Incorporated	2.91	$ 32.387 Millions	$ 11 Millions

Date modified: 2026-08-13T07:45:56+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.